Skip to main content
. Author manuscript; available in PMC: 2022 Sep 4.
Published in final edited form as: Neurochem Res. 2018 Aug 7;43(10):1869–1878. doi: 10.1007/s11064-018-2604-x

Figure 1: Schematic diagram of the study:

Figure 1:

Animals were subjected to 90 min or 3h MCAO after 14 days of bilateral ICV injection and randomized to IV candesartan (1 mg/kg) or saline at reperfusion. NTC: non-targeting control; shRNA: short hairpin RNA; KD: knock-down; ICV: intracerebroventricular; IV: intravenous; Hb: hemoglobin; MCAO: middle cerebral artery occlusion; VEGF: vascular endothelial growth factor.